RAB22A and breast carcinoma: RAB22A is a member of RAS oncogene family, and its expression is increased in many cancers such as breast cancer [10], colorectal cancer [11], osteosarcoma [12] and liver cancer [13], and it is involved in the proliferation, migration and immune regulation of malignant tumors.